Inhibition of Protein Deubiquitination by PR-619 Activates the Autophagic Pathway in OLN-t40 Oligodendroglial Cells

Cell Biochemistry and Biophysics

Volumn 67, Issue 1, 2013, Pages 149-160

  Seiberlich, Veronika ^a   Borchert, Janika ^a   Zhukareva, Victoria ^b   Richter Landsberg, Christiane ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

^b LifeSensors Inc   (United States)

Author keywords

Deubiquitinating enzymes; Lysosomal degradation; Macroautophagy; Microtubules; p62; Tau protein

Indexed keywords

2,6 DIAMINOPYRIDINE 3,5 BIS(THIOCYANATE); 2,6-DIAMINOPYRIDINE-3,5-BIS(THIOCYANATE); AMINOPYRIDINE DERIVATIVE; DEUBIQUITINASE; LC3 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; PROTEINASE INHIBITOR; RAPAMYCIN; RNA BINDING PROTEIN; TAU PROTEIN; THIOCYANIC ACID DERIVATIVE;

ANIMAL; ARTICLE; AUTOPHAGY; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; LYSOSOME; METABOLISM; MICROTUBULE; RAT;

AMINOPYRIDINES; ANIMALS; AUTOPHAGY; CELL LINE; HUMANS; LYSOSOMES; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; PROTEASE INHIBITORS; RATS; RNA-BINDING PROTEINS; SIROLIMUS; TAU PROTEINS; THIOCYANATES; UBIQUITIN-SPECIFIC PROTEASES;

EID: 84883456654     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9622-8     Document Type: Article

References (53)

1. Gregersen, N. (2006). Protein misfolding disorders: Pathogenesis and intervention. Journal of Inherited Metabolic Disease, 29, 456-470.
2. Chin, L. S., Olzmann, J. A., & Li, L. (2010). Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochemical Society Transactions, 38, 144-149.
3. Dohm, C. P., Kermer, P., & Bahr, M. (2008). Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication. Neurodegenerative Diseases, 5, 321-338.
4. Richter-Landsberg, C., & Goldbaum, O. (2003). Stress proteins in neural cells: Functional roles in health and disease. Cellular and Molecular Life Sciences, 60, 337-349.
5. Schwartz, A. L., & Ciechanover, A. (2009). Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annual Review of Pharmacology and Toxicology, 49, 73-96. doi: 10. 1146/annurev. pharmtox. 051208. 165340.
6. Jellinger, K. A. (2009). Recent advances in our understanding of neurodegeneration. Journal of Neural Transmission, 116(9), 1111-1162. doi: 10. 1007/s00702-009-0240-y.
7. Wong, E., & Cuervo, A. M. (2010). Integration of clearance mechanisms: The proteasome and autophagy. Cold Spring Harbor Perspectives in Biology, 2(12), a006734. doi: 10. 1101/cshperspect. a006734.
8. Matsuda, N., & Tanaka, K. (2010). Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease? Journal of Alzheimers Disease, 19(1), 1-9. doi: 10. 3233/JAD-2010-1231.
9. Huang, Q., & Figueiredo-Pereira, M. E. (2010). Ubiquitin/proteasome pathway impairment in neurodegeneration: Therapeutic implications. Apoptosis, 15, 1292-1311.
10. Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009). Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annual Review of Biochemistry, 78, 363-397.
11. Olzmann, J. A., & Chin, L. S. (2008). Parkin-mediated K63-linked polyubiquitination. Autophagy, 4, 85-87.
12. Yao, T.-P. (2010). The role of ubiquitin in autophagy-dependent protein aggregate processing. Genes Cancer, 7, 779-786.
13. Lamark, T., & Johansen, T. (2012). Aggrephagy: Selective disposal of protein aggregates by macroautophagy. International Journal of Cell Biology, 2012, 736905.
14. Tyedmers, J., Mogk, A., & Bukau, B. (2010). Cellular strategies for controlling protein aggregation. Nature Reviews Molecular Cell Biology, 11(11), 777-788. doi: 10. 1038/nrm2993.
15. Mizushima, N., Yoshimori, T., & Levine, B. (2010). Methods in mammalian autophagy research. Cell, 140, 313-326.
16. Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 8(4), 445-544.
17. Jahreiss, L., Menzies, F. M., & Rubinsztein, D. C. (2008). The itinerary of autophagosomes: From peripheral formation to kiss-and-run fusion with lysosomes. Traffic, 9(4), 574-587. doi: 10. 1111/j. 1600-0854. 2008. 00701. x.
18. Kirkin, V., McEwan, D. G., Novak, I., & Dikic, I. (2009). A role for ubiquitin in selective autophagy. Molecular Cell, 34, 259-269.
19. Kraft, C., Peter, M., & Hofmann, K. (2010). Selective autophagy: Ubiquitin-mediated recognition and beyond. Nature Cell Biology, 12(9), 836-841. doi: 10. 1038/ncb0910-836.
20. Boland, B., & Nixon, R. A. (2006). Neuronal macroautophagy: From development to degeneration. Molecular Aspects of Medicine, 27(5-6), 503-519.
21. Klionsky, D. J. (2007). Autophagy: From phenomenology to molecular understanding in less than a decade. Nature Reviews Molecular Cell Biology, 8, 931-937.
22. Jaenen, S. B., Chaachouay, H., & Richter-Landsberg, C. (2010). Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes. Glia, 58, 1766-1774.
23. Ding, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D. B., et al. (2007). Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. American Journal of Pathology, 171(2), 513-524.
24. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447(7146), 859-863.
25. Seiberlich, V., Goldbaum, O., Zhukareva, V., & Richter-Landsberg, C. (2012). The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: Implications for neurodegenerative diseases. Biochimica Et Biophysica Acta-Molecular Cell Research, 1823, 2057-2068.
26. RichterLandsberg, C., & Heinrich, M. (1996). OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. Journal of Neuroscience Research, 45(2), 161-173.
27. Goldbaum, O., Oppermann, M., Handschuh, M., Dabir, D., Zhang, B., et al. (2003). Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. Journal of Neuroscience, 23, 8872-8880.
28. Neuhoff, V., Philipp, K., Zimmer, H. G., & Mesecke, S. (1979). Simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe-Seylers Zeitschrift Fur Physiologische Chemie, 360, 1657-1670.
29. Bove, J., Martinez-Vicente, M., & Vila, M. (2011). Fighting neurodegeneration with rapamycin: Mechanistic insights. Nature Reviews Neuroscience, 12(8), 437-452. doi: 10. 1038/nrn3068.
30. Amerik, A. Y., & Hochstrasser, M. (2004). Mechanism and function of deubiquitinating enzymes. Biochimica Et Biophysica Acta, 1695(1-3), 189-207.
31. Komander, D., Clague, M. J., & Urbe, S. (2009). Breaking the chains: Structure and function of the deubiquitinases. Nature Reviews Molecular Cell Biology, 10(8), 550-563. doi: 10. 1038/nrm2731.
32. Todi, S. V., & Paulson, H. L. (2011). Balancing act: Deubiquitinating enzymes in the nervous system. Trends in Neurosciences, 34, 370-382.
33. Li, Y. H., Schrodi, S., Rowland, C., Tacey, K., Catanese, J., et al. (2006). Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Human Mutation, 27, 1017-1023.
34. Proctor, C. J., Tangeman, P. J., & Ardley, H. C. (2010). Modelling the role of UCH-L1 on protein aggregation in age-related neurodegeneration. PLoS ONE, 5, 12.
35. Kessler, B. M., & Edelmann, M. J. (2011). PTMs in conversation: Activity and function of deubiquitinating enzymes regulated via post-translational modifications. Cell Biochemistry and Biophysics, 60, 21-38.
36. Vucic, D., Dixit, V. M., & Wertz, I. E. (2011). Ubiquitylation in apoptosis: A post-translational modification at the edge of life and death. Nature Reviews Molecular Cell Biology, 12, 439-452.
37. Ramakrishna, S., Suresh, B., & Baek, K.-H. (2011). The role of deubiquitinating enzymes in apoptosis. Cellular and Molecular Life Sciences, 68, 15-26.
38. Altun, M., Kramer, H. B., Willems, L. I., McDermott, J. L., Leach, C. A., et al. (2011). Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chemistry and Biology, 18, 1401-1412.
39. Kramer, H. B., Nicholson, B., Kessler, B. M., & Altun, M. (2012). Detection of ubiquitin-proteasome enzymatic activities in cells: Application of activity-based probes to inhibitor development. Biochimica Et Biophysica Acta, 1823(11), 2029-2037. doi: 10. 1016/j. bbamcr. 2012. 05. 014.
40. Richter-Landsberg, C., & Bauer, N. G. (2004). Tau-inclusion body formation in oligodendroglia: The role of stress proteins and proteasome inhibition. International Journal of Developmental Neuroscience, 22(7), 443-451.
41. Fellner, L., Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2011). Glial dysfunction in the pathogenesis of alpha-synucleinopathies: Emerging concepts. Acta Neuropathologica, 121(6), 675-693. doi: 10. 1007/s00401-011-0833-z.
42. Kuusisto, E., Kauppinen, T., & Alafuzoff, I. (2008). Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathology and Applied Neurobiology, 34(2), 169-180.
43. Johansen, T., & Lamark, T. (2011). Selective autophagy mediated by autophagic adapter proteins. Autophagy, 7, 279-296.
44. Ichimura, Y., & Komatsu, M. (2010). Selective degradation of p62 by autophagy. Seminars in Immunopathology, 32, 431-436.
45. Korolchuk, V. I., Menzies, F. M., & Rubinsztein, D. C. (2010). Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Letters, 584, 1393-1398.
46. Kuusisto, E., Suuronen, T., & Salminen, A. (2001). Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochemical and Biophysical Research Communications, 280(1), 223-228.
47. Schwarz, L., Goldbaum, O., Bergmann, M., Probst-Cousin, S., & Richter-Landsberg, C. (2012). Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. Journal of Molecular Neuroscience, 47, 256-266.
48. Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., et al. (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. Journal of Biological Chemistry, 282(33), 24131-24145.
49. Taillebourg, E., Gregoire, I., Viargues, P., Jacomin, A. C., Thevenon, D., et al. (2012). The deubiquitinating enzyme USP36 controls selective autophagy activation by ubiquitinated proteins. Autophagy, 8, 767-779.
50. Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., et al. (2006). Rapamycin alleviates toxicity of different aggregate-prone proteins. Human Molecular Genetics, 15(3), 433-442.
51. Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One, 6(9), e25416. doi: 10. 1371/journal. pone. 0025416.
52. Moreau, K., Luo, S., & Rubinsztein, D. C. (2010). Cytoprotective roles for autophagy. Current Opinion in Cell Biology, 22(2), 206-211. doi: 10. 1016/j. ceb. 2009. 12. 002.
53. Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C. J., & Rubinsztein, D. C. (2006). Rapamycin pre-treatment protects against apoptosis. Human Molecular Genetics, 15(7), 1209-1216.